Sort:
Issue
Senp1 mediates neuronal pyroptosis after subarachnoid hemorrhage in mice
Journal of Army Medical University 2024, 46(17): 1976-1984
Published: 15 September 2024
Abstract PDF (3.1 MB) Collect
Downloads:1
Objective

To investigate the mechanism of SUMO-specific protease 1 (Senp1) involved in neuronal pyroptosis in subarachnoid hemorrhage (SAH).

Methods

A total of 95 male C57BL/6 mice (6~8 weeks old) were randomly divided into sham group (n=15), SAH groups (for 6, 12, 24, 48 and 72 h, respectively, n=8, 7, 17, 6 and 6), SAH+AAV9-NC group (n=19), and SAH+AAV9-sh-Senp1 group (n=17). Mouse model of SAH was established by intravascular puncture in the left internal carotid artery. Neurobehavioral scoring was used to evaluate neurological function, HE staining and FJC staining were employed to observe brain injury, RT-PCR was conducted to detect the knockdown of Senp1, Western blotting was applied to measure the expression of Senp1, NOD-like receptor thermal protein domain associated protein 3 (NLRP3), gasdermin D (GSDMD), PYD and CARD domain containing (ASC) and Caspase-1, and immunofluorescence assay was performed to observe the locations of Senp1 and NLRP3.

Results

SAH caused the elevated expression of Senp1, which reached a peak in 24 h and located in the cortical neurons. Compared with the sham group, the expression of Senp1, NLRP3, GSDMD, ASC and Caspase-1 were significantly enhanced in the SAH groups (P<0.01), with aggravation of nerve injury and neurological deficits. Administration of AAV9-sh-Senp1 resulted in significantly improved nerve injury and function, decreased expression of above proteins (P<0.01), and inhibited neuron pyroptosis when compared with the SAH+AAV9-NC group.

Conclusion

Senp1 promotes the occurrence of neuronal pyroptosis and mediates neuronal injury after SAH.

Issue
Continuous lumbar drainage improves prognosis in patients with acute hydrocephalus after aneurysmal subarachnoid hemorrhage
Journal of Army Medical University 2024, 46(4): 384-389
Published: 28 February 2024
Abstract PDF (753.8 KB) Collect
Downloads:0
Objective

To analyze the influence of drainage volume on prognosis of acute hydrocephalus (AHC) after aneurysmal subarachnoid hemorrhage (aSAH) by continuous lumbar drainage.

Methods

A retrospective trial was conducted on 82 AHC patients after aSAH admitted to the First Affiliated Hospital of Chongqing Medical University between January 2017 and January 2022.In 6 months after discharge, modified Rankin Scale (mRS) score was used to evaluate the prognostic outcomes. Univariate and multivariate logistic regression analyses were performed on demographic factors, severity of subarachnoid hemorrhage (SAH) at admission, medical history, cerebral vasospasm, and lumbar drainage data.Then a nomogram prediction model was constructed.

Results

Univariate analysis found that World Federation of Neurosurgical Societies (WFNS) score, Hunt-Hess grade, modified Fisher grade, time for continuous lumbar drainage, shunt dependence, cerebral vasospasm, and drainage volume were factors affecting the prognosis of the patients.Then logistic regression analysis revealed that high WFNS score (OR: 3.25, 95%CI: 1.11~9.48), high modified Fisher grade (OR: 3.66, 95%CI: 1.08~12.35), shunt dependence (OR: 15.56, 95%CI: 1.22~198.57), and cerebral vasospasm (OR: 22.24, 95%CI: 3.08~160.68) were independent predictors for mRS score, while volume of continuous lumbar drainage (OR: 0.57, 95%CI: 0.40~0.82) was an independent protective factor.ROC curve analysis indicated a good predictive performance of the model (AUC=0.898, 95%CI: 0.935~0.861).Internal validation through Bootstrap method demonstrated excellent discriminatory ability of the model (C-index=0.950, 95%CI: 0.904~0.996;adjusted C-index: 0.934).

Conclusion

Increased volume of lumbar drainage is an independent protective factor for poor prognosis following aSAH and can improve the prognosis of SAH patients.

Review Article Issue
Nanomaterials for visualized tumor surgical navigation and postoperative recurrence inhibition
Nano Research 2023, 16(12): 13226-13249
Published: 14 December 2023
Abstract PDF (20.4 MB) Collect
Downloads:100

Preoperative localization of the tumor sites and intraoperative real-time monitoring are essential for precise surgery but are meanwhile challenging due to the lack of high-resolution, easy-to-operate, and fast visualization techniques. On the other hand, tumor recurrence and metastasis after surgery greatly reduce the survival rate of patients. Intervening tumor recurrence during surgery is a future direction of tumor treatment. Nanomaterials with external condition responsiveness (light, ultrasound, and magnetic field) can accurately assist intraoperative detection and surgical resection due to their functions such as tumor cell targeting, fluorescence imaging, and real time monitoring, providing a more accurate, shorter duration, and visualization method of surgical resection. Moreover, nanomaterials are versatile and can easily be tailored for application in different tumors. Locally filled or systemically circulating nanomaterials with slow drug release and residual tumor cell-targeting ability have promising applications in inhibiting tumor recurrence. Here, we review surgical navigation and postoperative recurrence interventional nanomaterials and their landscape in guiding tumor treatment. We summarize the classification and characteristics of these nanomaterials and discuss their application in the surgical navigation and recurrence inhibition of different tumors. We also provide an outlook on the challenges and future development of nanomaterials for visualized tumor surgical navigation and postoperative recurrence inhibition.

Review Article Issue
Nano-imaging agents for brain diseases: Environmentally responsive imaging and therapy
Nano Research 2023, 16(12): 13134-13163
Published: 06 November 2023
Abstract PDF (10.8 MB) Collect
Downloads:130

Precise imaging is essential for the accurate diagnosis and surgical guidance of brain diseases but it is challenging due to the difficulties in crossing the blood-brain barrier (BBB), the difficulties in disease lesion targeting, and the limited contrast in the brain environment. Nano-imaging agents were characterized by functionalized modifications, high contrast, small size, and high biocompatibility, thus providing advantages in BBB crossing, brain targeting, imaging resolution, and real-time monitoring, holding great potential in brain disease imaging. Specific characteristics in brain environment and brain diseases (e.g., marker proteins on the BBB, the pathogenic proteins in the neurodegenerative diseases or brain tumors, and the tumor and inflammatory microenvironment) provide opportunities for the functionalized nano-imaging agents to improve BBB crossing and disease targeting. Moreover, the versatile nano-imaging agents are endowed with therapeutic agents to facilitate the theranostics of brain diseases. Here, we summarized the common materials and imaging techniques of nano-imaging agents and their imaging treatment applications. We discussed their BBB penetration, environmental response for disease targeting, and therapeutic effects. We also provided insights on the advantages, challenges, and application of nano-imaging agents in detecting and treating brain diseases such as neurodegenerative diseases, brain tumors, stroke, and traumatic brain injury. These discussions will help develop nano-imaging agents-based theranostic platforms for the precise diagnosis and treatment of brain diseases.

Total 4
1/11GOpage